Perinatal group B streptococcal disease.

[1]  A. Schuchat,et al.  Risk Factors for Invasive, Early-Onset Escherichia coli Infections in the Era of Widespread Intrapartum Antibiotic Use , 2006, Pediatrics.

[2]  S. Vermund,et al.  Use of Vaginally Administered Chlorhexidine During Labor to Improve Pregnancy Outcomes , 2006, Obstetrics and gynecology.

[3]  A. Haines,et al.  Carriage of group B streptococcus in pregnant women from Oxford, UK , 2006, Journal of Clinical Pathology.

[4]  S. Schrag,et al.  The prevention of neonatal group B streptococcal disease: a report by a working group of the Medical Screening Society , 2005, Journal of medical screening.

[5]  R. Feldman,et al.  Vaccination against Group B streptococcus , 2005, Expert review of vaccines.

[6]  B. Vohr,et al.  Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. , 2004, JAMA.

[7]  A. Charlett,et al.  Early‐onset neonatal group B streptococcal infection in London: 1990–1999 , 2004, BJOG : an international journal of obstetrics and gynaecology.

[8]  A. Schuchat,et al.  Trends in Sepsis-Related Neonatal Mortality in the United States, 1985–1998 , 2004, The Pediatric infectious disease journal.

[9]  M. Warner,et al.  Characterization of group B streptococci recovered from infants with invasive disease in England and Wales. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  N. Verlander,et al.  Group B streptococcal disease in UK and Irish infants younger than 90 days , 2004, The Lancet.

[11]  P. Heath,et al.  Estimated early-onset group B streptococcal neonatal disease , 2003, The Lancet.

[12]  A. Schuchat,et al.  Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. , 2003, The Lancet. Infectious diseases.

[13]  M. Pearlman.  Prevention of early-onset group B streptococcal disease in newborns. , 2003, Obstetrics and gynecology.

[14]  A. Schuchat,et al.  A Population-Based Comparison of Strategies to Prevent Early-Onset Group B Streptococcal Disease in Neonates , 2003 .

[15]  Stephanie Schrag,et al.  Prevention of Perinatal Group B Streptococcal Disease Revised Guidelines from CDC , 2002 .

[16]  K. O'Brien,et al.  Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. , 2002, Pediatrics.

[17]  S. Oddie,et al.  Risk factors for early onset neonatal group B streptococcal sepsis: case-control study , 2002, BMJ : British Medical Journal.

[18]  W. Poole,et al.  Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. , 2002, The New England journal of medicine.

[19]  K. O'Brien,et al.  Early-onset neonatal sepsis in the era of group B streptococcal prevention. , 2001, Pediatrics.

[20]  C. Peckham,et al.  Meningitis in infancy in England and Wales: follow up at age 5 years , 2001, BMJ : British Medical Journal.

[21]  P. Azimi,et al.  The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. , 2001, American journal of obstetrics and gynecology.

[22]  A. Breathnach,et al.  Confirmed group B streptococcus infection: the tip of the iceberg , 2001, Archives of disease in childhood. Fetal and neonatal edition.

[23]  M. Dryden,et al.  Universal maternal screening for neonatal group B streptococcal disease , 2000, The Lancet.

[24]  P. H. Roy,et al.  Rapid detection of group B streptococci in pregnant women at delivery. , 2000, The New England journal of medicine.

[25]  E. Main,et al.  Prevention of early-onset invasive neonatal group B streptococcal disease in a private hospital setting: the superiority of culture-based protocols. , 2000, American journal of obstetrics and gynecology.

[26]  A. Nicoll,et al.  Neonatal group B streptococcal infection in South Bedfordshire, 1993–1998 , 2000, Archives of disease in childhood. Fetal and neonatal edition.

[27]  R. Platt,et al.  Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  A. Schuchat,et al.  Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. , 2000, The New England journal of medicine.

[29]  J. N. Martin,et al.  Neonatal sepsis and death caused by resistant Escherichia coli: possible consequences of extended maternal ampicillin administration. , 1999, American journal of obstetrics and gynecology.

[30]  J. Gould,et al.  Preventing Early-onset Group B Streptococcal Sepsis: Strategy Development Using Decision Analysis , 1999, Pediatrics.

[31]  A. Schuchat.  Group B streptococcus , 1999, The Lancet.

[32]  Bignardi Ge.  Surveillance of neonatal group B streptococcal infection in Sunderland. , 1999 .

[33]  A. Schuchat,et al.  Impact of a risk-based prevention policy on neonatal group B streptococcal disease. , 1998, American journal of obstetrics and gynecology.

[34]  T. Asrat,et al.  Potential consequences of widespread antepartal use of ampicillin. , 1998, American journal of obstetrics and gynecology.

[35]  L. Moses,et al.  Early onset group B streptococcal neonatal infection in Oxford 1985-96 , 1998, Archives of disease in childhood. Fetal and neonatal edition.

[36]  C. Baker,et al.  Antimicrobial Susceptibilities of Group B Streptococci Isolated between 1992 and 1996 from Patients with Bacteremia or Meningitis , 1998, Antimicrobial Agents and Chemotherapy.

[37]  A. Schuchat,et al.  Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program. , 1998, The Journal of infectious diseases.

[38]  J. Strauss,et al.  Premature rupture of the fetal membranes. , 1998, The New England journal of medicine.

[39]  J. Miranda,et al.  Timing of Intrapartum Ampicillin and Prevention of Vertical Transmission of Group B Streptococcus , 1998, Obstetrics and gynecology.

[40]  N. F. Jacobs,et al.  Neonatal early-onset Escherichia coli disease. The effect of intrapartum ampicillin. , 1998, Archives of pediatrics & adolescent medicine.

[41]  A. Schuchat,et al.  Opportunities for Prevention of Perinatal Group B Streptococcal Disease: A Multistate Surveillance Analysis , 1997, Obstetrics and gynecology.

[42]  L. Wright,et al.  Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. , 1997, Pediatrics.

[43]  W. Gozansky,et al.  Prevention practices for perinatal group B streptococcal disease: A multi‐state surveillance analysis , 1997, Obstetrics and gynecology.

[44]  K. Nicolaides,et al.  Evolution of Maternofetal Transport of Immunoglobulins During Human Pregnancy , 1996, American journal of reproductive immunology.

[45]  J. Siegel,et al.  Prevention of early‐onset group B streptococcal disease: another look at single‐dose penicillin at birth , 1996, Obstetrics and gynecology.

[46]  D. Isaacman,et al.  Effect of number of blood cultures and volume of blood on detection of bacteremia in children. , 1996, The Journal of pediatrics.

[47]  A. Schuchat,et al.  Barriers to prevention of perinatal group B streptococcal disease. , 1995, The Pediatric infectious disease journal.

[48]  Boe Nm.  Group B streptococcal infections in pregnancy. , 1994 .

[49]  G. Cutter,et al.  Strategies for the Prevention of Early‐Onset Neonatal Group B Streptococcal Sepsis: A Decision Analysis , 1994, Obstetrics and gynecology.

[50]  P. Duff,et al.  An Analysis of the Cost-Effectiveness of Selected Protocols for the Prevention of Neonatal Group B Streptococcal Infection , 1994, Obstetrics and gynecology.

[51]  A. Schuchat,et al.  Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development. , 1994, Epidemiologic reviews.

[52]  A. Schuchat,et al.  Comparison of prevention strategies for neonatal group B streptococcal infection: A population‐based economic analysis , 1993, JAMA.

[53]  A. Schuchat,et al.  Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. , 1992, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[54]  C. Broome,et al.  American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn: Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. , 1992, Pediatrics.

[55]  R. Matorras,et al.  Intrapartum chemoprophylaxis of early-onset group B streptococcal disease , 1991 .

[56]  S. Garland,et al.  Group B Streptococcus (GBS) and Neonatal Infections: The Case for Intrapartum Chemoprophylaxis , 1991, The Australian & New Zealand journal of obstetrics & gynaecology.

[57]  A. Schuchat,et al.  Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. , 1990, The Journal of infectious diseases.

[58]  M. Hallman,et al.  Prevention of Neonatal Group B Streptococcal Disease: Intrapartum Detection and Chemoprophylaxis of Heavily Colonized Parturients , 1989, Obstetrics and gynecology.

[59]  K. Boyer,et al.  Antimicrobial prophylaxis of neonatal group B streptococcal sepsis. , 1988, Clinics in perinatology.

[60]  W. Morales,et al.  Prevention of neonatal group B streptococcal sepsis by the use of a rapid screening test and selective intrapartum chemoprophylaxis. , 1986, American journal of obstetrics and gynecology.

[61]  K. Boyer,et al.  Prevention of early‐onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis , 1986, The New England journal of medicine.

[62]  R. Rivers,et al.  Group B streptococcal colonisation and the outcome of pregnancy. , 1986, The Journal of infection.

[63]  Jane M. Deeley,et al.  The effect of intrapartum chemoprophylaxis on the vertical transmission of group B streptococci , 1983, British journal of obstetrics and gynaecology.

[64]  T. Yeh,et al.  Penicillin in infants weighing two kilograms or less with early-onset Group B streptococcal disease. , 1983, The New England journal of medicine.

[65]  C. Rosenfeld,et al.  SINGLE-DOSE PENICILLIN PROPHYLAXIS OF NEONATAL GROUP-B STREPTOCOCCAL DISEASE Conclusion of a 41 Month Controlled Trial , 1982, The Lancet.

[66]  T. Baskett,et al.  Perinatal group B streptococcal colonization and infection. , 1982, American journal of obstetrics and gynecology.

[67]  R. Mayon-White,et al.  Group B streptococcal systemic disease in Great Britain. , 1981, The Journal of infection.

[68]  R. Rivers,et al.  Nosocomial transmission of group B streptococci. , 1981, British medical journal.

[69]  H. Dillon,et al.  A prospective study of group B streptococcal bacteriuria in pregnancy. , 1981, American journal of obstetrics and gynecology.

[70]  C. Rosenfeld,et al.  Single-dose penicillin prophylaxis against neonatal group B streptococcal infections. A controlled trial in 18,738 newborn infants. , 1980, The New England journal of medicine.

[71]  E. Mason,et al.  Failure of penicillin to eradicate group B streptococcal colonization in the pregnant woman. A couple study. , 1979, American journal of obstetrics and gynecology.

[72]  E. Mason,et al.  Ampicillin prevents intrapartum transmission of group B streptococcus. , 1979, JAMA.

[73]  F. Barrett,et al.  Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. , 1973, The Journal of pediatrics.

[74]  R. Feigin,et al.  Group B beta hemolytic streptococcal meningitis in infants. , 1973, The Journal of pediatrics.

[75]  P. Mills.  Follow-up after sterilisation. , 1968, Lancet.

[76]  R. Fry.  FATAL INFECTIONS BY HÆMOLYTIC STREPTOCOCCUS GROUP B , 1938 .

[77]  R. Lancefield,et al.  THE SEROLOGICAL DIFFERENTIATION OF PATHOGENIC AND NON-PATHOGENIC STRAINS OF HEMOLYTIC STREPTOCOCCI FROM PARTURIENT WOMEN , 1935, The Journal of experimental medicine.